149 related articles for article (PubMed ID: 37773924)
1. Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis.
Taylor MR; Cole SW; Strom J; Brazauskas R; Baker KS; Phelan R; Buchbinder D; Hamilton B; Schoemans H; Shaw BE; Sharma A; Bhatt NS; Badawy SM; Winestone LE; Preussler JM; Mayo S; Jamani K; Nishihori T; Lee MA; Knight JM
Blood Adv; 2023 Nov; 7(22):6830-6838. PubMed ID: 37773924
[TBL] [Abstract][Full Text] [Related]
2. Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.
Knight JM; Rizzo JD; Logan BR; Wang T; Arevalo JM; Ma J; Cole SW
Clin Cancer Res; 2016 Jan; 22(1):69-78. PubMed ID: 26286914
[TBL] [Abstract][Full Text] [Related]
3. Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful.
Shaw BE; Brazauskas R; Millard HR; Fonstad R; Flynn KE; Abernethy A; Vogel J; Petroske C; Mattila D; Drexler R; Lee SJ; Horowitz MM; Rizzo JD
Cancer; 2017 Dec; 123(23):4687-4700. PubMed ID: 28817182
[TBL] [Abstract][Full Text] [Related]
4. Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Wood WA; Le-Rademacher J; Syrjala KL; Jim H; Jacobsen PB; Knight JM; Abidi MH; Wingard JR; Majhail NS; Geller NL; Rizzo JD; Fei M; Wu J; Horowitz MM; Lee SJ
Cancer; 2016 Jan; 122(1):91-8. PubMed ID: 26439325
[TBL] [Abstract][Full Text] [Related]
5. Molecular Correlates of Socioeconomic Status and Clinical Outcomes Following Hematopoietic Cell Transplantation for Leukemia.
Knight JM; Rizzo JD; Wang T; He N; Logan BR; Spellman SR; Lee SJ; Verneris MR; Arevalo JMG; Cole SW
JNCI Cancer Spectr; 2019 Dec; 3(4):pkz073. PubMed ID: 31763620
[TBL] [Abstract][Full Text] [Related]
6. Randomized Controlled Trial of Isha Kriya versus Observation to Improve Quality of Life in Hematopoietic Cell Transplantation Recipients.
Chopra M; Naik RR; Naik R; Sahni J; Bala K; Ahlawat J; Anand A; Singh C; Jandial A; Jain A; Prakash G; Khadwal A; Malhotra P; Lad DP
Transplant Cell Ther; 2023 Aug; 29(8):530.e1-530.e5. PubMed ID: 37192731
[TBL] [Abstract][Full Text] [Related]
7. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial.
Knight JM; Rizzo JD; Hari P; Pasquini MC; Giles KE; D'Souza A; Logan BR; Hamadani M; Chhabra S; Dhakal B; Shah N; Sriram D; Horowitz MM; Cole SW
Blood Adv; 2020 Feb; 4(3):467-476. PubMed ID: 32027744
[TBL] [Abstract][Full Text] [Related]
8. Psychological well-being and gene expression in Korean adults: The role of age.
Lee SH; Choi I; Choi E; Lee M; Kwon Y; Oh B; Cole SW
Psychoneuroendocrinology; 2020 Oct; 120():104785. PubMed ID: 32622293
[TBL] [Abstract][Full Text] [Related]
9. Loneliness, eudaimonia, and the human conserved transcriptional response to adversity.
Cole SW; Levine ME; Arevalo JM; Ma J; Weir DR; Crimmins EM
Psychoneuroendocrinology; 2015 Dec; 62():11-7. PubMed ID: 26246388
[TBL] [Abstract][Full Text] [Related]
10. Quality-of-Life Trajectories in Adolescent and Young Adult versus Older Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Mathanda RR; Hamilton BK; Rybicki L; Advani AS; Colver A; Dabney J; Ferraro C; Hanna R; Kalaycio M; Lawrence C; McLellan L; Sobecks R; Majhail NS; Rotz SJ
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1505-1510. PubMed ID: 32439476
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of decisional regret among patients who underwent allogeneic hematopoietic stem cell transplantation and associations with quality of life and clinical outcomes.
Cusatis RN; Tecca HR; D'Souza A; Shaw BE; Flynn KE
Cancer; 2020 Jun; 126(11):2679-2686. PubMed ID: 32154926
[TBL] [Abstract][Full Text] [Related]
12. Changes in eudaimonic well-being and the conserved transcriptional response to adversity in younger breast cancer survivors.
Boyle CC; Cole SW; Dutcher JM; Eisenberger NI; Bower JE
Psychoneuroendocrinology; 2019 May; 103():173-179. PubMed ID: 30703712
[TBL] [Abstract][Full Text] [Related]
13. Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood.
Lin C; Sajeev G; Stiff PJ; Brunstein CG; Cutler C; Sanz G; Lindemans CA; Rezvani AR; Hanna R; Koh LP; Maziarz RT; Hwang WYK; Song Y; Liu Q; Manghani R; Sivaraman S; Signorovitch J; Horwitz ME; Sung AD
Transplant Cell Ther; 2023 Jan; 29(1):52.e1-52.e9. PubMed ID: 36179986
[TBL] [Abstract][Full Text] [Related]
14. Quality of life 5 or more years post-autologous hematopoietic stem cell transplant.
Byar KL; Eilers JE; Nuss SL
Cancer Nurs; 2005; 28(2):148-57. PubMed ID: 15815185
[TBL] [Abstract][Full Text] [Related]
15. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Hong S; Brazauskas R; Hebert KM; Ganguly S; Abdel-Azim H; Diaz MA; Beattie S; Ciurea SO; Szwajcer D; Badawy SM; Gratwohl AA; LeMaistre C; Aljurf MDSM; Olsson RF; Bhatt NS; Farhadfar N; Yared JA; Yoshimi A; Seo S; Gergis U; Beitinjaneh AM; Sharma A; Lazarus H; Law J; Ulrickson M; Hashem H; Schoemans H; Cerny J; Rizzieri D; Savani BN; Kamble RT; Shaw BE; Khera N; Wood WA; Hashmi S; Hahn T; Lee SJ; Rizzo JD; Majhail NS; Saber W
Cancer; 2021 Feb; 127(4):609-618. PubMed ID: 33085090
[TBL] [Abstract][Full Text] [Related]
16. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research.
Auletta JJ; Kou J; Chen M; Bolon YT; Broglie L; Bupp C; Christianson D; Cusatis RN; Devine SM; Eapen M; Hamadani M; Hengen M; Lee SJ; Moskop A; Page KM; Pasquini MC; Perez WS; Phelan R; Riches ML; Rizzo JD; Saber W; Spellman SR; Stefanski HE; Steinert P; Tuschl E; Yusuf R; Zhang MJ; Shaw BE
Transplant Cell Ther; 2023 Jun; 29(6):346.e1-346.e10. PubMed ID: 36924931
[TBL] [Abstract][Full Text] [Related]
17. PROMIS measures can be used to assess symptoms and function in long-term hematopoietic cell transplantation survivors.
Shaw BE; Syrjala KL; Onstad LE; Chow EJ; Flowers ME; Jim H; Baker KS; Buckley S; Fairclough DL; Horowitz MM; Lee SJ
Cancer; 2018 Feb; 124(4):841-849. PubMed ID: 29072787
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial.
Knight JM; Syrjala KL; Majhail NS; Martens M; Le-Rademacher J; Logan BR; Lee SJ; Jacobsen PB; Wood WA; Jim HSL; Wingard JR; Horowitz MM; Abidi MH; Fei M; Rawls L; Rizzo JD
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2256-2263. PubMed ID: 27565521
[TBL] [Abstract][Full Text] [Related]
19. The Promoting Resilience in Stress Management (PRISM) intervention for adolescents and young adults receiving hematopoietic cell transplantation: a randomized controlled trial protocol.
Fladeboe KM; Scott S; Comiskey L; Zhou C; Yi-Frazier JP; Rosenberg AR
BMC Palliat Care; 2022 May; 21(1):82. PubMed ID: 35585525
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Pretransplantation Quality of Life and Its Post-Transplantation Longitudinal Change after Allogeneic Hematopoietic Cell Transplantation: A Prospective Study That Administered the Short-Form Health Survey (SF-12) and EuroQol 5.
Kurosawa S; Yamaguchi T; Mori A; Tsukagoshi M; Okuda I; Ikeda M; Fuji S; Yamashita T; Ogawa C; Ito A; Tanaka T; Inamoto Y; Kim SW; Fukuda T
Transplant Cell Ther; 2021 Nov; 27(11):935.e1-935.e9. PubMed ID: 34371214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
